HHS, NIH announce development of universal vaccine for COVID-19 and influenza
- In 2025, a universal vaccine combining protection against COVID-19 and influenza is planned, based on a next-generation platform unveiled by federal health agencies to eliminate the need for annual updates.
- This initiative addresses the current situation where influenza and COVID-19 shots are given as separate doses and are revised annually to target the most prevalent virus variants.
- This platform, called Generation Gold Standard, extends protection beyond strain-specific limits using updated traditional vaccine technology and aims to prevent future pandemics.
- Moderna's mRNA-1083 vaccine completed Phase 3 trials in June 2024 with positive data, but FDA feedback suggests an extended review timeline targeting approval in 2026.
- Officials plan to begin clinical trials in 2026 and hope to make universal vaccines available by 2029, while emphasizing rigorous safety, transparency, and efficacy standards.
71 Articles
71 Articles
Trump reveals bombshell vaccine shift that has experts terrified
The Trump administration has unveiled two significant initiatives aimed at enhancing vaccine safety and reducing the frequency of vaccinations for Americans. These efforts, led by the Department of Health and Human Services (HHS), focus on increasing transparency in vaccine development and pioneering new “universal” vaccines to combat multiple viral strains with a single dose. HHS […]

HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics
FRIDAY, May 2, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services and the National Institutes of Health announced a new initiative called "Generation Gold Standard" to develop next-generation, universal vaccines using a beta-propiolactone (BPL)-inactivated, whole-virus platform.
Vaccine revolution: Scientists develop vaccines that don't need refrigeration
The first human trial of a vaccine that doesn't need to be refrigerated has begun in the UK. If successful, it could save millions of vaccines that are currently lost through improper storage. Half of the vaccines produced worldwide are thrown away every year, largely due to temperature fluctuations.

HHS, NIH announce development of universal vaccine for COVID-19 and influenza
The National Institutes of Health and the Department of Health and Human Services announced the development of a "next-generation, universal vaccine platform," intended to create a universal COVID-19 and influenza shot that won't require updates.Currently, the flu and COVID-19 vaccines, which are administered separately, are updated every year to best combat the active strains of the viruses. Government officials say vaccines developed under Gen…
HHS Touts Universal Flu, Coronavirus Vaccine Initiative While Casting Doubt on Future of Seasonal Covid-19 Shots
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat that hasn’t been achieved for the past 45: the development of a universal flu vaccine that could protect against…
Coverage Details
Bias Distribution
- 47% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage